MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma

HMGA2Overexpression-Induced Ovarian Surface Epithelial Transformation Is Mediated Through Regulation of EMT Genes

(2011) Jingjing Wu et al.   CANCER RESEARCH

Oncogenic Ras Regulates BRIP1 Expression to Induce Dissociation of BRCA1 from Chromatin, Inhibit DNA Repair, and Promote Senescence

(2011) Zhigang Tu et al.   DEVELOPMENTAL CELL

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

(2011) Shiyu Zhang et al.   GYNECOLOGIC ONCOLOGY

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis

(2011) Anna Yemelyanova et al.   MODERN PATHOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

(2010) Robert J. Kurman et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers

(2010) C. J. Creighton et al.   CANCER RESEARCH

Frequent Downregulation of miR-34 Family in Human Ovarian Cancers

(2010) D. C. Corney et al.   CLINICAL CANCER RESEARCH

Regulation of HMGA1 Expression by MicroRNA-296 Affects Prostate Cancer Growth and Invasion

(2010) Jian-Jun Wei et al.   CLINICAL CANCER RESEARCH

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

(2010) Ahmed Ashour Ahmed et al.   JOURNAL OF PATHOLOGY

HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma

(2010) Aparna Mahajan et al.   MODERN PATHOLOGY

miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors

(2010) Patryk Moskwa et al.   MOLECULAR CELL

The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes

(2010) Anna-Barbara Stittrich et al.   NATURE IMMUNOLOGY

HMGA2: A Potential Biomarker Complement to P53 for Detection of Early-stage High-grade Papillary Serous Carcinoma in Fallopian Tubes

(2009) Jian-Jun Wei et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Suppression of Nonhomologous End Joining Repair by Overexpression of HMGA2

(2009) A. Y.J. Li et al.   CANCER RESEARCH

Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer

(2009) Christian Parr et al.   EUROPEAN JOURNAL OF CANCER

Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis

(2009) Kazi Mokim Ahmed et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Li–Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube

(2009) Wa Xian et al.   JOURNAL OF PATHOLOGY

Modulation of microRNA processing by p53

(2009) Hiroshi I. Suzuki et al.   NATURE

Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis

(2009) K Levanon et al.   ONCOGENE

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

(2009) Miguel F. Segura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

(2008) Joshua Z Press et al.   BMC CANCER

HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition

(2008) Sylvie Thuault et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact

(2008) Keren Levanon et al.   JOURNAL OF CLINICAL ONCOLOGY